The dementia world has been stirred by a recent paper reporting the drug Lecanemab’s effect on slowing cognitive decline in people with early Alzheimer’s Disease[1]. In Alzheimer's disease, two key proteins – tau and amyloid beta – build up into tangles and plaques,...









